Public views on vaccine pricing

How to cite

Chan, Yee Wah Lisa; Wang, Liang Choon; Rai, Birendra. 2021. "Public views on vaccine pricing." AEA RCT Registry. AEARCTR-0007522. https://doi.org/10.1257/rct.7522-2.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Yee Wah Lisa Chan* , Liang Choon Wang , Birendra Rai

* Primary investigator

Registry ID
AEARCTR-0007522
DOI
https://doi.org/10.1257/rct.7522-2.0
First registered
Last updated
Status
Completed
Trial dates
2021-04-17 – 2021-05-31
Countries
United States of America ()
Registry record
http://www.socialscienceregistry.org/trials/7522

Abstract

Global pricing of vaccines against infectious diseases is an important determinant of global public health outcomes as it affects the production and distribution of vaccines across countries. Pricing of vaccines remains a contentious issue because there is a dilemma: ensuring vaccines are affordable to poorer countries which have a relatively high burden of disease compared to richer countries, while also providing pharmaceutical firms with sufficient incentives for the research, development and innovation of vaccines. As a result, there have been calls for equity-based pricing, where prices are based on a country’s ability to pay. Using an online randomised controlled survey experiment, we will analyse the relative effects of providing different types of information on public support for equity-based pricing of vaccines.

Experimental design

The study will involve a randomised controlled choice experiment where we will try to infer the extent of public support for equity-based pricing of vaccines across different countries. The experiment will involve multiple treatment arms. Each arm will contain several stages, but the main difference will be whether and what type of information is provided to participants before they make their pricing decisions.

Design details

Randomization method
Randomizer in Qualtrics with the option "evenly present elements".
Randomization unit
Individual
Clusters
720 individuals
Observations
1440 observations (720 individuals x 2 stages)
Arms
90 individuals per treatment arm
Primary outcomes
1) A binary variable that is equal to 1 if the participant chooses prices consistent with equity-based pricing, and 0 otherwise. 2) A binary variable that is equal to 1 if the participant responds "Yes" to the question "Should the firm make some overall profit from its pricing across different countries?", and 0 otherwise. There are a number of different scenarios and stages. Therefore, outcome variables are defined at the scenario level and stage level.

Cited by

No citation data available for this registration yet.

Keywords